Reports on a study showing that a blood test is the most effective means of detecting prostate cancer. Comparison with the digital rectal exam; Recommendation for an annual prostate specific...
making it the second most common cancer in men. Screening for prostate cancer typically involves a combination of adigital rectal exam (DRE)and aprostate-specific antigen (PSA) blood test. However, the use of DRE
Prostate-specific antigen (PSA) test.This blood test checks the amount of a protein calledPSA,which is produced by prostate cells. Higher levels may be a sign of cancer. By themselves, they are not proof you have prostate cancer. Higher levels could also point to an enlarged prostate or pr...
Your doctor will also ask for blood tests, including a check of prostate-specific antigen (PSA) levels, to look for other signs that the cancer is spreading. PSA is a protein made by the prostate gland. A rise in PSA is one of the first signs your cancer may be growing. But PSA lev...
Prostate cancer is an abnormal growth of cells in the prostate gland. The main risk factors for developing prostate cancer are...
The CELLSEARCH® CTC Test is a simple, actionable blood test that helps oncologists assess the prognosis of patients with metastatic breast, prostate*, or colorectal cancer. The CELLSEARCH® CTC Test is:The first and only clinically validated, FDA-cleared blood test for enumerating circulating ...
A team of researchers from Cleveland Clinic, Louis Stokes Cleveland VA Medical Center, Kaiser Permanente Northwest, and other clinical sites have demonstrated that a new blood test known as IsoPSA detects prostate cancer more precisely than current tests
Doctors test for prostate cancer in one of two ways. One is through a rectal exam in which a doctor feels the gland and for any issues with it. The other way to test for prostate cancer is through prostate-specific antigen testing, ablood testcommonly known as PSA. ...
Stray cancer cells in the blood mean that a tumor has spread or is likely to, many doctors believe. A test that can capture such cells has the potential to transform care for many types of cancer, especially breast, prostate, colon and lung. Initially, doctors want to use the test to ...
There is ablood test, the previously mentioned PSA test, which is used as a marker for diseases of the prostate, but it is not specific for cancer. When used in combination with the DRE, ithelps to detect cases. But PSA levels become elevated after a DRE which makes the timing of tes...